首页 | 本学科首页   官方微博 | 高级检索  
检索        

住院部抗生素处方中不合理联用方式的调查分析
引用本文:陈旭俊,曹胡林.住院部抗生素处方中不合理联用方式的调查分析[J].临床合理用药杂志,2009,2(6):90-91.
作者姓名:陈旭俊  曹胡林
作者单位:湖北省荆州市公安县中医院药剂科,434300
摘    要:抗生素的联合应用在对住院患者的感染性疾病防治中非常普遍,同时采取不合理联用方式的现象也时有发生。这不仅会造成药物资源的浪费,增加患者的经济负担,还会导致细菌产生耐药性和患者机体的菌群失调。本调查旨在分析其不合理联用方式,为临床合理联合用药提供参考。

关 键 词:抗生素  处方  联用  不合理  调查研究

The treatment of Chinese medicine on hepatic fibrosis
Institution:LIN Yu-hui, DENG Min, YU Xiao-yan. (The Central People's Hospital of Zhanjiang City, Guangdong, Zhanjiang 524037, China)
Abstract:Hepatic fibrosis is the result of the hepatic necrosis and inflammatory. Hepatic fibrosis is known as the chronic and progressive pathological process of dysplasia of connective tissue including collagen fiber, elastic fiber and amino polysacchafide. Moreover, hyperplasia of collagen fibers are more prominent. The characteristic pathological change is the deposition and hyperplasia of collagen fiber in portal area and hepatic lobule, and hepatic lobule was integral. Liver Cirrhosis is the further development of liver cirrhosis,the hepatic lobule rebuilding, the fake lobule and nodes form. At the same time, fibrous septum form in portal area and Central venous area. Therefore, it is necessary to looking for effective drugs to block and delay the occurrence of hepatic fibrosis. Recently, attention has been focused on a potential therapeutic of traditional chinese medicine, that is the treatment to anti-hepatic fibrosis through multi-directions and multi-levels and multi-target.
Keywords:Chinese compound formula  Compound  Active ingredient  Hepatic fibrosis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号